MAPK15
Reaktivität: Human
WB
Wirt: Kaninchen
Polyclonal
unconjugated
Applikationshinweise
Western Blot (1:1000) Immunohistochemistry (1:10-50) The optimal working dilution should be determined by the end user.
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Liquid
Buffer
In PBS (0.09 % sodium azide)
Konservierungsmittel
Sodium azide
Vorsichtsmaßnahmen
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Lagerung
4 °C,-20 °C
Informationen zur Lagerung
Store at 4°C. For long term storage store at -20°C. Aliquot to avoid repeated freezing and thawing.
Klevernic, Stafford, Morrice, Peggie, Morton, Cohen: "Characterization of the reversible phosphorylation and activation of ERK8." in: The Biochemical journal, Vol. 394, Issue Pt 1, pp. 365-73, (2006) (PubMed).
Iavarone, Acunzo, Carlomagno, Catania, Melillo, Carlomagno, Santoro, Chiariello: "Activation of the Erk8 mitogen-activated protein (MAP) kinase by RET/PTC3, a constitutively active form of the RET proto-oncogene." in: The Journal of biological chemistry, Vol. 281, Issue 15, pp. 10567-76, (2006) (PubMed).
Saelzler, Spackman, Liu, Martinez, Harris, Abe: "ERK8 down-regulates transactivation of the glucocorticoid receptor through Hic-5." in: The Journal of biological chemistry, Vol. 281, Issue 24, pp. 16821-32, (2006) (PubMed).
Target
MAPK15
(Mitogen-Activated Protein Kinase 15 (MAPK15))